Abstract:Aortic aneurysms (AAs) are dilations of the aorta, that are often fatal upon rupture. Diagnostic radiological techniques such as ultrasound (US), magnetic resonance imaging (MRI), and computed tomography (CT) are currently used in clinical practice for early diagnosis as well as clinical follow-up for preemptive surgery of AA and prevention of rupture. However, the contemporary imaging-based risk prediction of aneurysm enlargement or life-threatening aneurysm-rupture remains limited as these are restricted to visual parameters which fail to provide a personalized risk assessment. Therefore, new insights into early diagnostic approaches to detect AA and therefore to prevent aneurysm-rupture are crucial. Multiple new techniques are developed to obtain a more accurate understanding of the biological processes and pathological alterations at a (micro)structural and molecular level of aortic degeneration. Advanced anatomical imaging combined with molecular imaging, such as molecular MRI, or positron emission tomography (PET)/CT provides novel diagnostic approaches for in vivo visualization of targeted biomarkers. This will aid in the understanding of aortic aneurysm disease pathogenesis and insight into the pathways involved, and will thus facilitate early diagnostic analysis of aneurysmal disease. In this study, we reviewed these molecular imaging modalities and their association with aneurysm growth and/or rupture risk and their limitations. Furthermore, we outline recent pre-clinical and clinical developments in molecular imaging of AA and provide future perspectives based on the advancements made within the field. Within the vastness of pre-clinical markers that have been studied in mice, molecular imaging targets such as elastin/collagen, albumin, matrix metalloproteinases and immune cells demonstrate promising results regarding rupture risk assessment within the pre-clinical setting. Subsequently, these markers hold potential as a future diagnosticum of clinical AA assessment. However currently, clinical translation of molecular imaging is still at the onset. Future human trials are required to assess the effectivity of potentially viable molecular markers with various imaging modalities for clinical rupture risk assessment.

Using Molecular Targets to Predict and Treat Aortic Aneurysms.

Molecular targets in aortic aneurysm for establishing novel management paradigms

Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Current Pharmacological Management of Aortic Aneurysm

The mechanism and therapy of aortic aneurysms

Molecular Imaging of Aortic Aneurysm and Its Translational Power for Clinical Risk Assessment

Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm

Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study

MicroRNAs: Novel Players in Aortic Aneurysm

Integrative multi-omics analyses reveal vesicle transport as a potential target for thoracic aortic aneurysm

Potential Medication Treatment According to Pathological Mechanisms in Abdominal Aortic Aneurysm

[Advances in Non-Invasive Treatment of Aortic Diseases].

Progress on the Role of Vascular Endothelial Cells in the Formation of Aortic Aneurysms

New Indicators for Systematic Assessment of Aortic Morphology: a Narrative Review

Nano-Biomaterials for the Delivery of Therapeutic and Monitoring Cues for Aortic Diseases

Molecular Mechanisms in Genetic Aortopathy-Signaling Pathways and Potential Interventions

Matricellular Proteins: Potential Biomarkers and Mechanistic Factors in Aortic Aneurysms.

Nanoparticle-Assisted Diagnosis and Treatment for Abdominal Aortic Aneurysm

Targeting autophagy in aortic aneurysm and dissection

Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression